- Despite Better Q2 Trends, Tight-fisted Spending Expected for Remainder of 2012, Goldman Sachs Survey Says
July 11, 2012 / GenomeWeb Daily News
- Leerink Swann Upgrades Illumina; Revises Estimates for Life Tech, Thermo Fisher, Others
July 23, 2012 / GenomeWeb Daily News
- Goldman Sachs Upgrades Cepheid and Myriad, Restarts Thermo Fisher Coverage
September 23, 2011 / GenomeWeb Daily News
- Goldman Sachs Resumes Coverage of Illumina
May 3, 2012 / GenomeWeb Daily News
- Goldman Sachs Revises Estimates for Life Science Tools Firms
April 13, 2012 / GenomeWeb Daily News